Tempus ECG-Low EF vs KardiaPro
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is to screen for low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older at risk of heart failure, using existing 12-lead ECG recordings collected in a healthcare facility. This tool is ideal for aiding clinicians in identifying patients who may require further evaluation for heart failure, particularly in a diagnostic setting.
View Tempus ECG-Low EF →Choose KardiaPro if…
Choose KardiaPro if you need a comprehensive, web-based platform for remote patient monitoring of ECG, blood pressure, and weight data. This tool is best suited for managing and reviewing longitudinal cardiac patterns and biometric data between appointments, enabling clinicians to track trends, detect arrhythmias, and make informed decisions for patients with chronic cardiovascular conditions.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | KardiaPro |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Software, integrated into healthcare facility workflows | Cloud-hosted, Web-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaProKardiaPro offers a comprehensive web-based portal for remote monitoring, allowing healthcare professionals to easily manage and review patient ECG, blood pressure, and weight data. It features a customizable ECG inbox and automated summary reports for efficient data review and trend visualization. In contrast, Tempus ECG-Low EF does not have a dedicated user interface and integrates into existing healthcare facility workflows, which might be less intuitive for direct interaction.
Clinical Value
KardiaProKardiaPro provides FDA-cleared AI for arrhythmia detection and other cardiac determinations, along with remote monitoring of ECG, blood pressure, and weight data, offering a broader scope of continuous patient oversight. While Tempus ECG-Low EF is FDA-cleared for detecting signs of low LVEF from 12-lead ECGs, its utility is focused on a single condition and is not intended for patient monitoring.
Pricing & Value
KardiaProBoth tools require contacting the vendor for pricing information. However, KardiaPro explicitly states that it is reimbursable using existing CPTu00ae codes, which can significantly enhance its value proposition for healthcare providers. This transparency regarding reimbursement offers a clearer path to financial viability for adopting KardiaPro.
Enterprise Readiness
KardiaProKardiaPro is a cloud-hosted, web-based platform with HIPAA compliance and SOC-2 certification, indicating robust enterprise readiness. It also offers seamless integration with KardiaMobile devices and KardiaStation for point-of-care solutions, and supports EHR/third-party interoperability. Tempus ECG-Low EF is deployed as software integrated into healthcare facility workflows and is HIPAA compliant, but the extent of its broader enterprise features like comprehensive data management and integration capabilities is less detailed.
Innovation
KardiaProKardiaPro, through AliveCor, has a history of pioneering mobile ECG technology and has been recognized for its innovation in health. It offers a comprehensive remote monitoring platform that integrates various biometric data, showcasing a broader innovative approach to patient care beyond just ECG analysis. Tempus ECG-Low EF is an innovative AI-powered tool for LVEF detection, but it represents a more specialized application within the broader field of cardiology AI.
Support & Docs
TieBoth companies are established in the healthcare AI space, suggesting a reasonable level of support and documentation. However, specific details regarding the depth and accessibility of their support and documentation were not extensively provided in the given information or readily available through general web searches for a direct comparison.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | KardiaPro |
|---|---|---|
| Product Name | Tempus ECG-Low EF | KardiaPro |
| Company | Tempus AI | AliveCor |
| Primary Function | Analyzes 12-lead ECGs to detect signs associated with low LVEF (u226440%) in patients 40+ years at risk of heart failure. | Web-based portal for remote monitoring of patient ECG, blood pressure, and weight data with FDA-cleared AI for arrhythmia detection. |
| Target Patient Population/Data Type | Patients 40 years or older at risk of heart failure; analyzes resting, non-ambulatory 12-lead ECG recordings. | Patient ECG, blood pressure, and weight data; integrates with KardiaMobile, KardiaMobile 6L, and KardiaStation devices. |
| Output/Key Detection | Binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation. | FDA-cleared AI for arrhythmia detection and other cardiac determinations; automated summary reports and trend visualization. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or KardiaPro
Backers
Who funded each tool's parent company.